Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region

被引:55
作者
Farzan, M [1 ]
Chung, S [1 ]
Li, WH [1 ]
Vasilieva, N [1 ]
Wright, PL [1 ]
Schnitzler, CE [1 ]
Marchione, RJ [1 ]
Gerard, C [1 ]
Gerard, NP [1 ]
Sodroski, J [1 ]
Choe, H [1 ]
机构
[1] Childrens Hosp, Permutter Lab, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M206784200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Entry of most primary human immunodeficiency virus, type 1 (HIV-1) isolates into their target cells requires the cellular receptor CD4 and the G protein-coupled chemokine coreceptor CCR5. An acidic, tyrosine-rich, and tyrosine-sulfated domain of the CCR5 amino terminus plays a critical role in the ability of CCR5 to serve as an HIV-1 coreceptor, and tyrosine-sulfated peptides based on this region physically associate with the HIV-1 envelope glycoprotein gp120 and slow HIV-1 entry into CCR5-expressing cells. Here we show that the same tyrosine-sulfated peptides, but not their unsulfated analogs, can restore the HIV-1 coreceptor activity of a CCR5 variant lacking residues 2-17 of its amino terminus. Additionally, these sulfated peptides restored the ability of this CCR5 variant to mobilize calcium in response to the chemokines macrophage inflammatory factors 1alpha and 1beta. These observations show that a tyrosine-sulfated region of the CCR5 amino terminus can function independently to mediate association of chemokines and the HIV-1 envelope glycoprotein with the remaining domains of CCR5.
引用
收藏
页码:40397 / 40402
页数:6
相关论文
共 45 条
[1]   HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor [J].
Bieniasz, PD ;
Fridell, RA ;
Aramori, I ;
Ferguson, SSG ;
Caron, MG ;
Cullen, BR .
EMBO JOURNAL, 1997, 16 (10) :2599-2609
[2]   Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity [J].
Blanpain, C ;
Lee, B ;
Vakili, J ;
Doranz, BJ ;
Govaerts, C ;
Migeotte, I ;
Sharron, M ;
Dupriez, V ;
Vassart, G ;
Doms, RW ;
Parmentier, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :18902-18908
[3]   The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry [J].
Bleul, CC ;
Farzan, M ;
Choe, H ;
Parolin, C ;
ClarkLewis, I ;
Sodroski, J ;
Springer, TA .
NATURE, 1996, 382 (6594) :829-833
[4]   Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity [J].
Brelot, A ;
Heveker, N ;
Pleskoff, O ;
Sol, N ;
Alizon, M .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4744-4751
[5]   The orphan seven-transmembrane receptor Apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1 [J].
Choe, H ;
Farzan, M ;
Konkel, M ;
Martin, K ;
Sun, Y ;
Marcon, L ;
Cayabyab, M ;
Berman, M ;
Dorf, ME ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
JOURNAL OF VIROLOGY, 1998, 72 (07) :6113-6118
[6]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[7]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[8]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628
[9]   Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120 [J].
Cormier, EG ;
Persuh, M ;
Thompson, DAD ;
Lin, SW ;
Sakmar, TP ;
Olson, WC ;
Dragic, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) :5762-5767
[10]   Mapping the determinants of the CCRS amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes [J].
Cormier, EG ;
Tran, DNH ;
Yukhayeva, L ;
Olson, WC ;
Dragic, T .
JOURNAL OF VIROLOGY, 2001, 75 (12) :5541-5549